Arkolith/Insider Trading/APUS/Form 4/A

Inscobee Inc.

10% OwnerApimeds Pharmaceuticals US, Inc. (APUS) · full profile →Form 4/A · filed Jun 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 12, 2025Conversion(C)44K$2.60$115K2.1M
May 12, 2025Conversion(C)71K$2.60$185K2.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 12, 2025Conversion(C)0—$00
May 12, 2025Conversion(C)0—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001474506-25-000109) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML